KIMBERLY HADLER: Open Payments
NPI 1770697062 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$367 in 5 payments from 5 companies in 2025. Trend: 2023 $85 · 2024 $177 · 2025 $367
Food & beverage: $367
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $98 |
| Teva Pharmaceuticals USA, Inc. | 1 | $87 |
| Novo Nordisk Inc | 1 | $32 |
| Janssen Scientific Affairs, LLC | 1 | $25 |
Products named: INGREZZA, CAPLYTA, Ozempic, INVEGA SUSTENNA.
Industry payments across IN — which companies pay providers there.
